Douglas G. Gray
Corporate Secretary bei BIOHAVEN LTD.
Profil
Douglas G.
Gray is currently a Partner & Chairman-Life Science Practice Group at Locke Lord LLP and also serves as Secretary at Biohaven Ltd.
He previously worked as Secretary & Director at Biohaven Pharmaceutical Holding Co. Ltd.
and as a Partner at Edwards Wildman Palmer LLP.
Gray received a graduate degree from the University of Notre Dame and an undergraduate degree from Yale University.
Aktive Positionen von Douglas G. Gray
Unternehmen | Position | Beginn |
---|---|---|
BIOHAVEN LTD. | Corporate Secretary | - |
Locke Lord LLP
Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Corporate Officer/Principal | 01.01.2015 |
Ehemalige bekannte Positionen von Douglas G. Gray
Unternehmen | Position | Ende |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03.10.2022 |
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Corporate Officer/Principal | - |
Ausbildung von Douglas G. Gray
University of Notre Dame | Graduate Degree |
Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOHAVEN LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Locke Lord LLP
Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Commercial Services |